Evidence map›Paper›PMID 40100597›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2025

Transplantation and Monitoring of a Murine Minor Histocompatibility Antigen-Mismatched Model of Graft-Versus-Host Disease.

Amir Shamshirian, Karshing Chang, Kate H Gartlan

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Amir ShamshirianImmunopathology Laboratory, Infection & Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD, Australia.
Karshing ChangImmunopathology Laboratory, Infection & Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD, Australia.
Kate H GartlanImmunopathology Laboratory, Infection & Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD, Australia. Kate.Gartlan@qimrberghofer.edu.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Murine models of allogeneic stem cell transplantation (allo-SCT) have been a valuable tool in expanding our understanding of graft-versus-host disease (GVHD) immunopathology, providing a platform to manipulate allo-SCT and mimic the clinical scenarios observed in humans. These systems have been instrumental in advancing our understanding of the disease mechanisms and facilitating the exploration of novel therapeutic strategies. This chapter outlines the transplantation and monitoring methods in a murine minor histocompatibility antigen-mismatched model of GVHD model using C3H.SW donors and C57BL/6J recipients, aiming to provide researchers with a comprehensive guide to effectively use this model for advancing GVHD treatment and improving patient outcomes in allo-SCT.

Indexed as

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationMinor Histocompatibility AntigensAnimalsDisease Models, AnimalMiceMice, Inbred C57BLTransplantation, HomologousMinor Histocompatibility AntigensAllotransplantationBone marrow transplantationFlow cytometryGraft-versus-host diseaseMagnetic bead separationMouseStem cell transplantationT cell

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.